Progressive deficiency will lead to mental depression, peripheral neuropathy and fatigue
As a result, PBMs have been unable to exclude either brand without political risk
Among other things, there is no guarantee that planned or ongoing studies will be completed as planned, that future study results will be consistent with expectations or study results to date, that retatrutide will prove to be a safe and effective treatment for obesity or overweight and knee osteoarthritis or other potential indications, that retatrutide will receive regulatory approval, or that Lilly will execute its strategy as expected
And, this individual impact is good for the economy
What is the risk of diverticular disease (diverticulosis or diverticulitis) associated with GLP1 receptor agonist therapy in adults with type 2 diabetes?
Zeng SY, Liu YF, Liu JH, Zeng ZL, Xie H, Liu JH